LSG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.282200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.885200E-01
Normal-vs-Stage2
8.737200E-01
Normal-vs-Stage3
2.658600E-01
Normal-vs-Stage4
5.295000E-01
Stage1-vs-Stage2
8.961000E-01
Stage1-vs-Stage3
5.645900E-02
Stage1-vs-Stage4
4.855400E-01
Stage2-vs-Stage3
7.111900E-02
Stage2-vs-Stage4
3.988800E-01
Stage3-vs-Stage4
7.936000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.531000E-01
Normal-vs-AfricanAmerican
6.371600E-01
Normal-vs-Asian
7.860200E-01
Caucasian-vs-AfricanAmerican
2.626800E-01
Caucasian-vs-Asian
5.746400E-01
AfricanAmerican-vs-Asian
3.849200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.091800E-01
Normal-vs-Female
9.614200E-01
Male-vs-Female
7.703400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.793000E-01
Normal-vs-Age(41-60Yrs)
7.623000E-01
Normal-vs-Age(61-80Yrs)
9.797800E-01
Normal-vs-Age(81-100Yrs)
8.883000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.884600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.531600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.092800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.694200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.084800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.279200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.753000E-01
Normal-vs-Daily Drinker
7.100800E-01
Normal-vs-Weekly Drinker
9.119000E-01
Normal-vs-Occasional Drinker
5.667000E-01
Normal-vs-Social Drinker
6.280800E-01
Non Drinker-vs-Daily Drinker
7.030800E-01
Non Drinker-vs-Weekly Drinker
9.038800E-01
Non Drinker-vs-Occasional Drinker
1.459210E-01
Non Drinker-vs-Social Drinker
2.568800E-01
Daily Drinker-vs-Weekly Drinker
6.276600E-01
Daily Drinker-vs-Occasional Drinker
6.574200E-02
Daily Drinker-vs-Social Drinker
1.156790E-01
Weekly Drinker-vs-Occasional Drinker
2.161800E-01
Weekly Drinker-vs-Social Drinker
3.084600E-01
Occasional Drinker-vs-Social Drinker
7.582000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.782600E-01
Normal-vs-Grade 2
6.882400E-02
Normal-vs-Grade 3
4.258200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.450500E-02
Grade 1-vs-Grade 3
1.788240E-02
Grade 1-vs-Grade 4
2.782600E-01
Grade 2-vs-Grade 3
1.878990E-01
Grade 2-vs-Grade 4
6.882400E-02
Grade 3-vs-Grade 4
4.258200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.707200E-01
Normal-vs-NonDiabetic
9.367200E-01
Diabetic-vs-NonDiabetic
1.959650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.788600E-01
Normal-vs-NoPancreatitis
9.848600E-01
Pancreatitis-vs-NoPancreatitis
5.503000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.894200E-01
Normal-vs-N1
8.780000E-01
N0-vs-N1
6.241600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.431200E-01
Normal-vs-TP53-NonMutant
7.389600E-01
TP53-Mutant-vs-TP53-NonMutant
7.878000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
